JPRN-UMIN000007221已完成未知
Multicenter Clinical Study Evaluating the Safety and Efficacy of Dasatinib Treatment and its Discontinuation in Patients with Chronic Phase Chronic Myelogenous Leukemia who had Reached Complete Molecular Response during Imatinib Therapy - Multicenter Clinical Study on the Safety and Efficacy of Dasatinib Discontinuation
Juntendo University School of Medicine0 个研究点目标入组 40 人开始时间: 2012年2月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Concurrent malignancy other than CML 2.Women who are pregnant or breastfeeding 3. A serious uncontrolled medical disorder that would impair the ability of the subjects to receive protocol therapy
研究者
相似试验
进行中（未招募）
1 期
A multi-centre clinical trial evaluating safety and patients' ability to independently use the medicinal product indicated in the treatment of erectile dysfunctioEUCTR2019-003073-25-PLAdamed Pharma S.A.400
已完成
2 期
A Multi-Centre Clinical Study to Evaluate the Safety and Effectiveness of the ESS505® Device to Prevent Pregnancy in Women Who Are Seeking Permanent ContraceptioWomen ages range 21 to 44 years desiring permanent contraceptionbirth controlcontraceptionNL-OMON39616Bayer40
进行中（未招募）
不适用
n-blinded Multicenter Study of Robotic-assisted Laparoscopic Partial NephrectomycT1 Renal CancerJPRN-jRCT1052190004Masato Fujisawa100
进行中（未招募）
1 期
Safety and tolerability during open-label treatment with LCZ696 in patients with chronic heart failure and reduced ejection fractioHeart failure with reduced ejection fractionMedDRA version: 20.0 Level: LLT Classification code 10019279 Term: Heart failure System Organ Class: 100000004849EUCTR2014-001971-30-PTovartis Pharma services AG1,980
进行中（未招募）
1 期
Safety and tolerability during open-label treatment with LCZ696 in patients with chronic heart failure and reduced ejection fractioEUCTR2014-001971-30-FIovartis Pharma services AG5,000